On Aug. 15, CMS issued the Final Negotiated Prices for Initial Price Applicability Year 2026 under the Inflation Reduction Act (IRA). Access the NewsBREAK to learn more.
AMCP recently hosted its third iteration of the IRA workshop series, bringing together health plans, pharmaceutical manufacturers, PBMs, research institutes, and patient advocacy organizations.
View AMCP letter urging Congress to support 12-month continuous eligibility for adults in Medicaid and the Children’s Health Insurance Program (CHIP) by passing the Stabilize Medicaid and CHIP Coverage Act
Meet Maher Abdel Sattar, FAMCP, MS, PharmD, a volunteer with AMCP for over 15 years and currently an Associate Director of Affairs Operations at a Pharmaceutical Company.
With 102 days to go until the 2024 general election, the race for the Oval Office is shaping up as a race to the finish between Vice President Kamala Harris and Republican Donald Trump. AMCP’s 2024 Election Outlook provides an in-depth look at the top-of-the-ticket candidates, forecast analyses for House, Senate, and gubernatorial elections, and critical information about the state of US politics. Source: Tiber Creek